ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Elite Pharmaceuticals Inc (QB)

Elite Pharmaceuticals Inc (QB) (ELTP)

0.53
-0.022
(-3.99%)
Closed 17 February 8:00AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.53
Bid
0.5101
Offer
0.549
Volume
5,052,323
0.445 Day's Range 0.53
0.1213 52 Week Range 0.7598
Market Cap
Previous Close
0.552
Open
0.4501
Last Trade
38
@
0.52164
Last Trade Time
Financial Volume
US$ 2,458,552
VWAP
0.486618
Average Volume (3m)
1,221,825
Shares Outstanding
1,068,273,108
Dividend Yield
-
PE Ratio
28.19
Earnings Per Share (EPS)
0.02
Revenue
56.63M
Net Profit
20.11M

About Elite Pharmaceuticals Inc (QB)

Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products which have been licensed to Lannett Company, Prasco, LLC, Epic Pharma... Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products which have been licensed to Lannett Company, Prasco, LLC, Epic Pharma, LLC, and TAGI Pharma. Elite operates a cGMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. For more information, visit www.elitepharma.com. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Carson City, Nevada, USA
Founded
-
Elite Pharmaceuticals Inc (QB) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker ELTP. The last closing price for Elite Pharmaceuticals (QB) was US$0.55. Over the last year, Elite Pharmaceuticals (QB) shares have traded in a share price range of US$ 0.1213 to US$ 0.7598.

Elite Pharmaceuticals (QB) currently has 1,068,273,108 shares in issue. The market capitalisation of Elite Pharmaceuticals (QB) is US$589.69 million. Elite Pharmaceuticals (QB) has a price to earnings ratio (PE ratio) of 28.19.

ELTP Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.00651.241642788920.52350.560.44511160620.53604704CS
40.048.163265306120.490.560.4458596120.50587328CS
12-0.0999-15.85966026350.62990.6450.44512218250.535363CS
260.3325168.354430380.19750.75980.18224219510.47427551CS
520.338176.0416666670.1920.75980.121315984310.40011904CS
1560.489051194.261294260.040950.75980.02689976280.25537615CS
2600.4395485.6353591160.09050.75980.0239720400.17953524CS

ELTP - Frequently Asked Questions (FAQ)

What is the current Elite Pharmaceuticals (QB) share price?
The current share price of Elite Pharmaceuticals (QB) is US$ 0.53
How many Elite Pharmaceuticals (QB) shares are in issue?
Elite Pharmaceuticals (QB) has 1,068,273,108 shares in issue
What is the market cap of Elite Pharmaceuticals (QB)?
The market capitalisation of Elite Pharmaceuticals (QB) is USD 589.69M
What is the 1 year trading range for Elite Pharmaceuticals (QB) share price?
Elite Pharmaceuticals (QB) has traded in the range of US$ 0.1213 to US$ 0.7598 during the past year
What is the PE ratio of Elite Pharmaceuticals (QB)?
The price to earnings ratio of Elite Pharmaceuticals (QB) is 28.19
What is the cash to sales ratio of Elite Pharmaceuticals (QB)?
The cash to sales ratio of Elite Pharmaceuticals (QB) is 10
What is the reporting currency for Elite Pharmaceuticals (QB)?
Elite Pharmaceuticals (QB) reports financial results in USD
What is the latest annual turnover for Elite Pharmaceuticals (QB)?
The latest annual turnover of Elite Pharmaceuticals (QB) is USD 56.63M
What is the latest annual profit for Elite Pharmaceuticals (QB)?
The latest annual profit of Elite Pharmaceuticals (QB) is USD 20.11M
What is the registered address of Elite Pharmaceuticals (QB)?
The registered address for Elite Pharmaceuticals (QB) is 321 W. WINNIE LANE, #104, CARSON CITY, NEVADA, 89703
What is the Elite Pharmaceuticals (QB) website address?
The website address for Elite Pharmaceuticals (QB) is www.elitepharma.com
Which industry sector does Elite Pharmaceuticals (QB) operate in?
Elite Pharmaceuticals (QB) operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SMKGSmart Card Marketing Systems Inc (PK)
US$ 0.0019
(189,900.00%)
9.86k
TVOGTurner Valley Oil and Gas Inc (CE)
US$ 0.0005
(49,900.00%)
247.03k
AASZDAtlantic Sapphire AS (QB)
US$ 1.09
(15,471.43%)
731
TIOGTingo Group Inc (CE)
US$ 0.015
(14,900.00%)
10.34k
FPWMCharlestowne Premium Beverages Inc (CE)
US$ 0.0001
(9,900.00%)
450
ZHCLFZenith Capital Corporation (CE)
US$ 0.0001
(-99.90%)
150
ELYSElys BMG Group Inc (CE)
US$ 0.000001
(-99.75%)
327
GRMCGoldrich Mining Company (CE)
US$ 0.000001
(-99.67%)
500
THMOThermoGenesis Holdings Inc (CE)
US$ 0.000001
(-99.67%)
1.16k
ELIQQElectriq Power Holdings Inc (CE)
US$ 0.0015
(-99.25%)
100
AFFUAffluence Corp (PK)
US$ 0.00025
(-37.50%)
230.6M
DPUIDiscount Print USA Inc (PK)
US$ 0.0002
(0.00%)
188.75M
PHILPHI Group Inc (PK)
US$ 0.0002
(0.00%)
161.7M
CBDDCBD of Denver Inc (PK)
US$ 0.0002
(0.00%)
150.4M
HMBLHUMBL Inc (PK)
US$ 0.0005
(0.00%)
143.28M

ELTP Discussion

View Posts
ElementalArcher25 ElementalArcher25 3 hours ago
I agree. I want the best price possible but if Naz can get an offer of 3 or more I would good with that but under 2 I would say wait but that's just mho.
👍️0
jour_trader jour_trader 3 hours ago
Not necessarily. If R&D pipeline really is robust, we need time to execute. R&D pre-FDA filing isn't worth more than an FDA filing, which is less than an approved and launched product. R&D formulation lately has been slow to move due to all of the recent product launches, which is the reason to look overseas and start accelerating new product formulation. 
👍️0
ElementalArcher25 ElementalArcher25 3 hours ago
Just remember the old saying a bird in the hand is better than 2 in the bush
👍️0
jour_trader jour_trader 3 hours ago
Likely the same result as Adderall IR & ER that were already crowded when Elite entered the market. We earned significant marketshare...
👍️0
ElementalArcher25 ElementalArcher25 3 hours ago
Yeah great ideal and what happens if 10 other generic drug makers get approved to manufacture Vyvanse over the next year?
👍️ 1 ❓️ 1
HGilS HGilS 4 hours ago
Wrong. Happy president day. Long weekend in the usa.
👍️0
Chasing Chasing 4 hours ago
so do clowns

Great minds think alike.
👍️ 1 💯 1
tombe tombe 4 hours ago
Love the stench of desperation. All messages have the same thumbs up and crowns. Mix it up a little bit to make it seem a little less transparent.
👍️ 1 😂 2
The ELTP King The ELTP King 4 hours ago
Nice...

The only reason The King has called for 2027 was so Elite would continue to gain market share on the currently approved products while developing and marketing even more.......... Increasing the value of the company !!!!!!!!!!!!!!!
👍️ 2 👑 2
The ELTP King The ELTP King 5 hours ago
Amazing post. Great minds think alike.

hope company doesn't get bought for at least another year and a half to get sales ramped up on Vyvanse and believe waiting ultimately will get us a higher position, particularly if on NASDAQ vs. Otc.
👍️ 2 👑 2
The ELTP King The ELTP King 5 hours ago
Great minds think alike.

Put me in the group that wants to see 4 more CC before a sale is reached. I can wait for the pot to cook some.

👍️ 2 👑 2
The ELTP King The ELTP King 5 hours ago
Nobody cares.

The only thing that matters is the buyout price in early 2027.

Any predictions on what share price will do Tuesday?
👍️ 2 👑 2
The ELTP King The ELTP King 5 hours ago
Every weekend is the EXACT same 48 hours.
👍️ 2 👑 2
tombe tombe 5 hours ago
It’s a long ass weekend no?
👍️0
kennyt 335 kennyt 335 6 hours ago
Thank you NASDAQ2020! Love #69 Vegas Baby! Go ELTP$$$$$$$
👍️ 2
NASDAQ2020 NASDAQ2020 7 hours ago
Elite Pharma Catalyst:

X 1. Cash Flow Positive - 5 years
X 2. Purchase building housing their cGMP registered facility for research, development, manufacturing and packaging of pharmaceutical products.
X 3. Adderall IR $335 Million IMS market Approved and Launched
X 4. Adderall XR $1.56 Billion IMS market Approved and Launched
X 5. Double digit quarterly revenues in millions
X 6. Create in house marketing and distribution: Kirko Kirkov, Doug Plassche and their teams
X 7. Prasco/Burel Adderall agreement - January 1st 2024
X 8. First shipment Adderall XR to Prasco/Burel Dec 2023
X 9. DEA increases manufacturing quotas for Adderall & Vyvance
X 10. Generic OxyContin - FIRST TO FILE FDA Aug 17, 2023 $720 Million
X 11. Generic Vyvanse - $4.7 BILLION - FDA submission Dec 2023
X 12. FDA Acceptance of Generic OxyContin Sept 2023
X 13. Lease additional manufacturing space and storage vault for new Needle Mover ANDAs - Jan 2024
__14. Dopamine Agonist Approval (probably Requip XL or Mirapex ER). $12 Million
__15. Obtain Full ownership of Adderall IR $ 335 Million from MIKAH
__16. Obtain Full ownership of Adderall XR $ 1.56 Billion from MIKAH
X 17. Vigabatrin Approval $233 Million
X 18. Pyros Vigabatrin -settle VigPoder trade mark challenge and LAUNCH
X 19. Generic Methotrexate Antimetabolite- Approval
X 20. Launch generic Methotrexate $63.4 Million
X 21. $50+ million in yearly revenues
X 22. Lowest PE ratio for OTC Healthcare sector
X 23. Become the ONLY company showing rapid growth on the OTC while being profitable
X 24. Put Opioids back on the Table- due to reduced risk of opioid litigation
X 25. Receive Analyst Coverage - Upgrade to Market Outperform - Zacks Investment Research
X 26. International Distribution - partnership Approval by Israeli Ministry of Health for European distribution License and Distribution Agreement by and between Elite Pharmaceuticals, Inc. and Dexcel Ltd.
X 27. Generic IR Adderall® Receives Marketing Approval From The Israeli Ministry Of Health Oct 2024
__28. Generate revenues over $20 million/quarter
X 29. Final Approval of New Manufacturing Facility/Expansion
__30. Double output of manufacturing and packaging facilities
X 31. Launch approved generic Tylenol with Codeine $47 Million
X 32. Launch approved generic Norco - hydrocodone acetaminophen IMS $300 Million
__33. Launch approved generic Percocet - oxycodone acetaminophen IMS $500 Million
__34. Launch approved generic Dolophine - methadone HCL tablets IMS $30 Million
X 35. Generic Vyvanse (The Golden Goose) Approval $4.3 Billion
__36. Positive BE Study for Concerta CNS Stimulant $1.2 Billion
X 37. LAUNCH $4.3 Billion Generic Vyvanse Dec 2024
__38. Generic Concerta- FDA submission $1.2 Billion
__39. Launch Adderall IR in Israel
__40. 100 million in yearly revenues
__41. Generic OxyContin Approval $720 Million
X 42. Accord/Elite prevail over Purdue in Generic OxyContin infringement suit - Dec 30, 2024
https://cafc.uscourts.gov/opinions-orders/23-1953.OPINION.12-30-2024_2443222.pdf

https://www.pacermonitor.com/public/case/51356241/PURDUE_PHARMA_LP_et_al_v_ELITE_LABORATORIES_INC,_et_al
__43. Launch generic OxyContin $720 Million
__44. Positive BE on NDA Unique ADF opioid - 90% cheaper than ADF without Naltrexone
__45. Resume R&D on SequestOx Abuse Deterrent Oxycodone
__46. $200 million in yearly revenue
__47. Patented NDA Unique ADF (w/o naltrexone) drug C in SequestOx reformulation trial
__48. Undisclosed Mikah ANDA(s)
__49. Undisclosed ANDAs/NDAs
__50. Generic Concerta Launch $1.2 Billion
__51. DollarLand PPS
__52. Uplist to NASDAQ exchange
__53. M&A advisory firm selected for buyout
__54. Perform Business Valuation
__55. Develop strategy set for sale of business
__56. Prepare marketing materials for sale
__57. The advisory firm begins to identify and approach potential buyers.
__58. Management teams present the company's strengths and growth potential to interested buyers
__59. Site visits by potential Buyers to inspect and meet management.
__60. Buyout Negotiations begin
__61. Buyout offer/s
__62. Buyer Identified
__63. Purchase Definitive Agreement
__64. Necessary regulatory approvals are obtained for transfer
__65. Buyout Vote of Board of Directors
__66. Halt Trading
__67. Shareholder vote on offer
__68. Buyout Closing Completed
__69. Vegas BABY !!!!!

ELTP
👍️ 4
kennyt 335 kennyt 335 7 hours ago
Wow Tuesday can’t get here soon enough! ELTP$$$$$$$
👍️ 2
kennyt 335 kennyt 335 7 hours ago
Thank you NASDAQ2020! Very informative Sir! Vegas coming our way soon! ELTP$$$$$$$
👍️ 1
HGilS HGilS 8 hours ago
I like the fact we have a third packaging machine that can be installed in no time. Not having a spare one was something that I identified as a risk.

I listened again to the teleconference and there are many hints about the future
👍 5
NASDAQ2020 NASDAQ2020 8 hours ago
I will add to list later tonight. I have to wait to get my iPad back from my bird.
👍️0
HGilS HGilS 8 hours ago
Intention and company strength are enough to raise interest
👍️0
NASDAQ2020 NASDAQ2020 8 hours ago
Buyout news spreading like a wild fire.

ELTP
👍️ 2
HGilS HGilS 8 hours ago
Looks good they just need numbers
👍️ 1
NASDAQ2020 NASDAQ2020 8 hours ago
M&A advisory firm selected
Perform Business Valuation
Develop strategy set for sale of business
Prepares marketing materials for sale
The advisory firm begins to identify and approach potential buyers.
Management teams present the company's strengths and growth potential to interested buyers
Site visits by potential Buyers may visit company facilities and meet management.
Negotiations
Buyout offer/s
Buyer Identified
Purchase Definitive Agreement
Necessary regulatory approvals are obtained for transfer
Buyout Vote of Board of Directors
Halt Trading
Shareholder vote on offer
Closing Completed

ELTP
👍️ 4
ElementalArcher25 ElementalArcher25 9 hours ago
I know 2 new investors that will be buying in Tuesday
👍️0
ElementalArcher25 ElementalArcher25 9 hours ago
Any predictions on what share price will do Tuesday?
👍️0
NASDAQ2020 NASDAQ2020 9 hours ago
Jammy got his wish for Nasrat to sell Elite.

ELTP
👍️ 1
kennyt 335 kennyt 335 11 hours ago
Thank you HGilS
👍️ 1
HGilS HGilS 11 hours ago
No they will halt it the way they publish the deal price only. They will reopen trading if there is a bidding war.
👍️ 1
HGilS HGilS 11 hours ago
Another virgin popping his cherry today.

Hey happy first post!!!
👍️ 1
kennyt 335 kennyt 335 11 hours ago
Thanks JT!
👍️0
jour_trader jour_trader 11 hours ago
I'd say if we are aggressive we can close out a deal within 4-5 months if we are already going to market. The process can move as fast or slow as Nasrat wants. We can hit pause on the sale if not getting enough interest to where the valuation Nasrat feels it should be.
👍️ 2 💯 1
kennyt 335 kennyt 335 11 hours ago
Hi HGilS, as lm new to a M/A if that’s the decision Nasrat makes, will they halt it if he finds a buyer because l read it may take a year to finalize if that’s the case! TIA from a long timer since 2011. ELTP $$$$$$$
👍️ 2
Pinsider Pinsider 11 hours ago
Put me in the group that wants to see 4 more CC before a sale is reached. I can wait for the pot to cook some.
👍 6
jctrdr jctrdr 12 hours ago
Have been Investor for Years!!  I'm 78, looking for Buy Out Now😁.  With CEO statements, I would think SP will Gap Up Tues.....any thoughts??
👍️ 4 ❓️ 1
luvwetscent luvwetscent 12 hours ago
I've got one
👍️0
snupoled snupoled 12 hours ago
Jour, with gratitude
I want highest possible price too, I'm a simple person from flyover counties, but instinct which is not facts has me around a buck tops, want to be wrong, otc consideration
Hoping CEO can wait 4 more Q's
I'm long so will benefit being wrong
Snup
👍 2 🩳 1
jour_trader jour_trader 13 hours ago
About half what we do today.", 527M O/S Feb 2014. $0.40, $2.10 & $2.75 were 3 options with $2.10 being communicated the most likely. This was pre-opioid crisis when Nasrat expected SequestOx tech to be on path to approval. The plan was to use this tech and create a "treadmill" of drugs we could apply it to and drive continual growth in opioid space and capture market. 
👍️ 3
kennyt 335 kennyt 335 13 hours ago
Here Here! ELTP$$$$$$$
👍️ 2
mrwrn2010 mrwrn2010 13 hours ago
The share price hit .75 several weeks ago. If anyone actually walks into the room and proposes that, they better be laughed out of the building.
🎓️ 1 👍️ 5 📣 1 ❤️ 1
snupoled snupoled 13 hours ago
Hgils thanks, should put PPS in overdrive
Any idea what our outstanding share count was when we had 2.50 valuation thrown around about 12 years ago , versus our outstanding share count today?
I will be adding again, but really hope company doesn't get bought for at least another year and a half to get sales ramped up on Vyvanse and believe waiting ultimately will get us a higher position, particularly if on NASDAQ vs. Otc.
Why not hyper psyched snup? Premiums on otc generally not that high, by my limited experience, but I have had some!
Best cc ever for me!
Snupdawgoled
👍️ 2
meshcan meshcan 14 hours ago
Hi Winechemist,
Hope you and your dad are doing well! Long time no talk :)
I would like to hear your professional opinion regarding recent CC and comments about launching Vyvanse, Reverse Split or merger acquisition.

Please let us know.
Thanks
👍️ 1
imanjen13 imanjen13 14 hours ago
Also Nas please add the 3rd quarter revenue number.
👍️ 1
HGilS HGilS 14 hours ago
I believe we can add
“PR about M&A company picked”
“PR about buyer identified”
“”PR about offer”
“PR about valuation”
“PR about strategy set”
“PR about negotiations”
“PR about marketing “
“Pr about vote of board”
“PR about shareholders vote”
“PR about closing”
“
👍️ 4 💯 1
snupoled snupoled 14 hours ago
Rocio, thanks, any thoughts on our share count and suitors bid/valuation for us.
Snup
👍️0
meshcan meshcan 14 hours ago
Our path is crystal clear and is happening prior to Aug 2026.
I know, we already have many longs that are millionaire with 0.5 pps but they are going to become multi-millionaire soon. 
Good luck to all longs here who trusted Nasrat with all up and down. He turned around an almost bankrupted company to one of the most successful and financially strong company ever that you never seen in OTC. Now is time 👍
👍️ 9 💯 2
imanjen13 imanjen13 14 hours ago
Typo correction 3/28/25 for Perc launch is my guess based upon Conf. call
👍️ 2
NASDAQ2020 NASDAQ2020 14 hours ago
Yeah give it away.
👍️ 2
Destiny Defined Destiny Defined 14 hours ago
I think people need to stop with the pie in the sky conjecture, and idk....maybe entertain the fact that Nasrat actually tells us the truth. Elite is in great shape. Nasrat is a very intelligent and hard working CEO, and in an extremely competitive and ever changing industry that's riddled with challenges/complexities that most here simply can't, and/or obviously don't comprehend. Give the guy a break, and just be happy that we're headed in the right direction with someone that actually cares at the helm.
We will all be handsomely rewarded in the end. Sit back, and relax, Jack.
🎓️ 1 👍️ 11 💯 5
NASDAQ2020 NASDAQ2020 14 hours ago
Any suggestions to add ?
👍️0

Your Recent History

Delayed Upgrade Clock